89 related articles for article (PubMed ID: 15805251)
21. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
[TBL] [Abstract][Full Text] [Related]
22. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
23. Molecular and cytogenetic characterization of a t(1;10;21) translocation in the human papillary thyroid cancer cell line TPC-1 expressing the ret/H4 chimeric transcript.
Jossart GH; Greulich KM; Siperstein AE; Duh Q; Clark OH; Weier HU
Surgery; 1995 Dec; 118(6):1018-23. PubMed ID: 7491517
[TBL] [Abstract][Full Text] [Related]
24. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
Valent A; Danglot G; Bernheim A
Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
[TBL] [Abstract][Full Text] [Related]
25. Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
Pierotti MA; Bongarzone I; Borrello MG; Mariani C; Miranda C; Sozzi G; Greco A
J Endocrinol Invest; 1995 Feb; 18(2):130-3. PubMed ID: 7629380
[No Abstract] [Full Text] [Related]
26. Frequency of close positioning of chromosomal loci detected by FRET correlates with their participation in carcinogenic rearrangements in human cells.
Gandhi M; Evdokimova V; Nikiforov YE
Genes Chromosomes Cancer; 2012 Nov; 51(11):1037-44. PubMed ID: 22887574
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract][Full Text] [Related]
28. Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells.
Gandhi MS; Stringer JR; Nikiforova MN; Medvedovic M; Nikiforov YE
Genes Chromosomes Cancer; 2009 Mar; 48(3):222-8. PubMed ID: 19025793
[TBL] [Abstract][Full Text] [Related]
29. A Case of Inv(1)(q23q31)
Rekhi B; Shetty O; Bapat P; Gurav M; Qureshi S
Int J Surg Pathol; 2021 Feb; 29(1):102-108. PubMed ID: 32489127
[TBL] [Abstract][Full Text] [Related]
30. Rapid physical mapping of the human trk protooncogene (NTRK1) to human chromosome 1q21-q22 by P1 clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy.
Weier HU; Rhein AP; Shadravan F; Collins C; Polikoff D
Genomics; 1995 Mar; 26(2):390-3. PubMed ID: 7601468
[TBL] [Abstract][Full Text] [Related]
31. Assignment of the human a-tropomyosin gene TPM3 to 1q22-->q23 by fluorescence in situ hybridisation.
Wilton SD; Eyre H; Akkari PA; Watkins HC; MacRae C; Laing NG; Callen DC
Cytogenet Cell Genet; 1995; 68(1-2):122-4. PubMed ID: 7956350
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
Vaishnavi A; Capelletti M; Le AT; Kako S; Butaney M; Ercan D; Mahale S; Davies KD; Aisner DL; Pilling AB; Berge EM; Kim J; Sasaki H; Park S; Kryukov G; Garraway LA; Hammerman PS; Haas J; Andrews SW; Lipson D; Stephens PJ; Miller VA; Varella-Garcia M; Jänne PA; Doebele RC
Nat Med; 2013 Nov; 19(11):1469-1472. PubMed ID: 24162815
[TBL] [Abstract][Full Text] [Related]
33. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.
Lee SJ; Li GG; Kim ST; Hong ME; Jang J; Yoon N; Ahn SM; Murphy D; Christiansen J; Wei G; Hornby Z; Lee DW; Park JO; Park YS; Lim HY; Hong SN; Kim SH; Kang WK; Park K; Park WY; Kim KM; Lee J
Oncotarget; 2015 Nov; 6(36):39028-35. PubMed ID: 26472021
[TBL] [Abstract][Full Text] [Related]
34. The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B-NTRK1 fusion.
Shinozaki-Ushiku A; Ishikawa S; Komura D; Seto Y; Aburatani H; Ushiku T
Gastric Cancer; 2020 Sep; 23(5):944-947. PubMed ID: 32189226
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic chromosomal translocations and human cancer (review).
Zheng J
Oncol Rep; 2013 Nov; 30(5):2011-9. PubMed ID: 23970180
[TBL] [Abstract][Full Text] [Related]
36. A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes.
Schubert L; Le AT; Hinz TK; Navarro AC; Nelson-Taylor SK; Nemenoff RA; Heasley LE; Doebele RC
Biol Open; 2023 Aug; 12(8):. PubMed ID: 37470475
[TBL] [Abstract][Full Text] [Related]
37. An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.
Bargas S; Mc Leer A; Mondet J; Chabre O; Laramas M
Eur J Endocrinol; 2022 Feb; 186(4):K5-K8. PubMed ID: 35118995
[TBL] [Abstract][Full Text] [Related]
38. N of 2 Responders with LMNA-NTRK1.
Lih CJ; Chen AP
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563357
[No Abstract] [Full Text] [Related]
39. TRKA expression and
Mauri G; Valtorta E; Cerea G; Amatu A; Schirru M; Marrapese G; Fiorillo V; Recchimuzzo P; Cavenago IS; Bonazzina EF; Motta V; Lauricella C; Veronese S; Tosi F; Maiolani M; Rospo G; Truini M; Bonoldi E; Christiansen J; Potts SJ; Siena S; Sartore-Bianchi A
J Clin Pathol; 2018 Oct; 71(10):926-931. PubMed ID: 29802225
[TBL] [Abstract][Full Text] [Related]
40. A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes.
Schubert L; Le AT; Hinz TK; Navarro A; Nelson-Taylor SK; Nemenoff RA; Heasley LE; Doebele RC
bioRxiv; 2023 Apr; ():. PubMed ID: 37066347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
